|
| Status |
Public on Nov 17, 2017 |
| Title |
9701417123_R02C02 |
| Sample type |
genomic |
| |
|
| Source name |
genomic DNA from 9701417123_R02C02
|
| Organism |
Homo sapiens |
| Characteristics |
age: 42
Sex: Male
race: African American
hiv: 1
idu: 0
hcv_dx: 0
smoking: 0
artadherence: 1
cd8t: 0.0695
cd4t: 0.129
nk: 0.0851
bcell: 0.0477
mono: 0.177
gran: 0.517
tissue: whole blood
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
DNAs were extracted from whole blood using the standard protocol.
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation 450K Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Description |
Sample 355
|
| Data processing |
GenomeStudio V2011.1
|
| |
|
| Submission date |
Jun 20, 2017 |
| Last update date |
Nov 17, 2017 |
| Contact name |
Ke Xu |
| E-mail(s) |
ke.xu@yale.edu
|
| Organization name |
Yale University
|
| Department |
department of psychiatry
|
| Street address |
300 George St.
|
| City |
New Haven |
| ZIP/Postal code |
06511 |
| Country |
USA |
| |
|
| Platform ID |
GPL16304 |
| Series (2) |
| GSE100264 |
DNA methylation signatures of injection illicit drug use (IDU) and hepatitis C (HCV) predict HIV pathophysiologic frailty I |
| GSE107082 |
DNA methylation signatures of injection illicit drug use (IDU) and hepatitis C (HCV) predict HIV pathophysiologic frailty |
|
